Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

It was a bold choice to host a preview screening of The Thinking Game, a documentary about AI company Google DeepMind and its ...

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...

Google’s DeepMind is reportedly holding back from publishing AI research papers over fears of losing its competitive edge.

Google’s artificial intelligence arm DeepMind has been holding back the release of its world-renowned research, as it seeks ...

Demis Hassabis, a childhood chess prodigy, said his experience with the game afforded him his first brush with AI. He was ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

The drug discovery company, which has partnerships with Eli Lilly and Novartis, is developing AI models to design drugs and ...

Demis, who was last year jointly awarded the Nobel Prize in Chemistry with Google DeepMind colleague Dr John Jumper for their ...

The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.